INTRODUCTION
Fibrates and their derivatives constitute a group of hypolipidemic agents which are used in the treatment of hypertriglyceridemia and combined hyperlipidemia. These fibrates belong to a structurally diverse group of compounds known as peroxisome proliferators, which have been shown to cause liver hepatomegaly, proliferation of peroxisomes and induction of many enzymes involved in peroxisomal and mitochondrial β-oxidation and ωoxidation of fatty acids (for review see (1) ). In the past number of years, significant progress has been made in understanding the mechanism of action of these peroxisome proliferators. These compounds activate the peroxisome proliferator-activated receptor alpha (PPARα), a member of the nuclear hormone receptor superfamily (2) . The PPARα binds as a heterodimer with the retinoid X receptor (RXR) to a peroxisome proliferator-response element (PPRE) located in the promoter region of target genes e.g. peroxisomal acyl-CoA oxidase (ACO) (3), P450
4A1
(CYP4A1) (4) , and the enoyl-CoA/3-hydroxyacyl-CoA hydratase/dehydrogenase multifunctional enzyme (5) . Targeted disruption of the PPARα gene resulted in lack of peroxisome proliferation, no hepatomegaly and lack of induction of peroxisome proliferator-regulated genes in response to peroxisome proliferators (6) (7) (8) . The PPARα has also been shown to play a critical role in the adaptive response to fasting in mice (8) (9) (10) (11) as the induction of several genes involved in lipid catabolism is abolished in the PPARα-null mice. In addition to the triglyceride lowering effect, fibrates also lower plasma cholesterol levels in humans (12) . Bezafibrate treatment of normolipidemic gallstone patients resulted in decreased levels of total, LDL-and VLDL-cholesterol, while HDL-cholesterol was unchanged. In addition, bezafibrate treatment changed the bile acid composition in bile with cholic acid being increased and chenodeoxycholic acid being decreased, suggesting an involvement of the PPARα in the regulation of expression of sterol 12α-hydroxylase and thereby affecting bile acid composition.
Bile acids are formed in the liver from cholesterol and their synthesis represents an important pathway for elimination of cholesterol from the body. The bile acid biosynthetic pathway involves a number of enzymatic modifications of the cholesterol backbone catalyzed by several P-450 enzymes, followed by β-oxidation of the cholesterol side chain and conjugation of the formed bile acid to glycine or taurine (for review see (13) ). The rate limiting step in bile acid formation is generally believed to be the 7α-hydroxylation of cholesterol, catalyzed by cholesterol 7α-hydrolxylase (CYP7A1). The sterol 12α-hydroxylase (CYP8B1) is a hepatic microsomal enzyme that acts at a branch-point in the bile acid synthetic pathway by catalyzing the conversion of 7α-hydroxy-4-cholesten-3-one to 7α,12αdihydroxy-4-cholesten-3-one. This conversion determines the ratio of cholic acid to chenodeoxycholic acid, and the balance may be important in the development of gallstones; chenodeoxycholic acid may, in contrast to cholic acid, reduce the degree of cholesterol saturation in bile, which is of importance for cholesterol gallstone formation. Sterol 12α-hydroxylase is highly regulated and many of the early studies carried out were involved in the regulation of the enzyme activity.
Clofibrate treatment increases sterol 12α-hydroxylase activity and mRNA level in rat liver microsomes (14, 15) . The enzyme was initially purified from rabbit liver microsomes by Ishida et al in 1992 and the activity was shown to be elevated by several treatments including starvation and administration of streptozotocin in rat (16) . Other studies showed that following starvation, both sterol 12αhydroxylase enzyme activity and mRNA levels were increased in rat and mouse, suggesting a possible transcriptional regulation in this case (17) , but the mechanism of this regulation was not understood. Recently, the structure of the sterol 12α-hydroxylase gene in rat, human and mouse (15, 18, 19) and the cDNA in rabbit (17) have been elucidated, providing important tools for detailed studies on the regulation of this gene.
As fibrates act as ligands for the PPARα and treatment with these compounds results in an altered bile acid synthesis, we examined the effects of these compounds on the expression of sterol 12α-hydroxylase. From in vivo experiements using the PPARα-null mouse model and in vitro experiments, we
show that the sterol 12α-hydroxylase gene is under regulation of the PPARα, activation of which results in a changed bile acid composition.
EXPERIMENTAL PROCEDURES
Animals and treatment -Ten to twelve week old wild-type or PPARα-null male mice on a pure Sv/129 genetic background (derived from the original colony of mixed background mice) (6) were housed in a temperature and light controlled environment. Mice were treated with a diet containing 0.1% (w/w) WY-14,643 (Calbiochem-Novabiochem Intl.) for one week or maintained on a normal chow diet. Fasting experiments were carried out for 24 hours and animals were sacrificed at 9.00 am. All mice had access to water ad libitum. Animals were euthanized by CO 2 asphyxiation followed by cervical dislocation, and liver and gallbladders were excised. The liver samples were frozen in liquid nitrogen and stored at -70 o C for preparation of total RNA. containing the rat gene. The fragment corresponded to bp -173 to +48 from the transcription start site (18) . The forward primer used was CTG ACC AAG CTC TGC TGT GTC and the reverse primer was CAG CCT CAG AGC AAG GTC CA.
The primers contained restriction sites for KpnI and MluI to facilitate cloning into the luciferase reporter vector pGL3 Basic (pGL3 12α). Sequences were verified using the ABI Prism Dye Terminator Ready-Reaction Kit (Perkin Elmer).
Mutations were introduced into the PPRE by polymerase chain reaction using QuikChange™ Site Directed Mutagenesis kit (Stratagene) using the following primers 5'-cctcagagca CT GTCCAAGGGCAtgggcgtttg-3' (pGL3 12α-M1) and 5'-cctcagagcaAGGTCC GC GGGCAtgggcgtttg-3' (pGL3 12α-M2) (mutations in the PPRE are underlined). The presence of the mutations were confirmed by sequencing.
Cells were co-transfected with pcDNA3.1+ (Invitrogen) containing the mouse PPARα cDNA as described (8) . The pSV-β-galactosidase vector was used to monitor transfection efficiency (Promega Corp., Madison, WI, USA). cpm of labeled probe was added to each reaction and incubations were carried out for 45 minutes on ice. The complexes were resolved on a 5% polyacrylamide gel in 1X TBE and the gel was dried and exposed to X-ray film overnight.
Bile acid analysis -Gallbladders were removed from untreated wild-type and PPARα-null mice and mice treated with WY-14,643 for one week. The gallbladders were minced in saline and hydrolyzed in 1 M KOH for 4 hours at Statistical analysis was performed using the SPSS version 9.0 and data was analyzed using one factor analysis of variance (ANOVA) followed by Tukey's test.
RESULTS

Sterol 12 -hydroxylase mRNA expression is regulated via PPAR -It has
previously been shown that sterol 12α-hydroxylase mRNA is induced in rat liver by the peroxisome proliferator clofibrate (15) . As the effects of peroxisome proliferators are mediated via the PPARα (6), we used the PPARα-null mouse model to examine the in vivo regulation of sterol 12α-hydroxylase. Feeding mice a WY-14,643 containing diet for one week resulted in a doubling of sterol 12αhydroxylase mRNA ( Fig. 1A ). However this upregulation was not evident in the PPARα-null mice which were also treated with WY-14,643, demonstrating that the peroxisome proliferator-mediated induction of sterol 12α-hydroxylase is dependent on the PPARα.
The cholesterol 7α-hydroxylase is considered as the rate limiting enzyme in bile acid biosynthesis, and we therefore examined the effect of WY-14,643 treatment on its expression. No apparent change by this treatment was observed in wild-type mice. However, the expression was considerably lower in the PPARα-null mice, with an individual variation in expression. We also examined the regulation of the peroxisomal acyl-CoA oxidase (ACO), the rate-limiting enzyme in peroxisomal β-oxidation, which is widely used as a marker enzyme for PPARα-regulated gene expression. ACO expression was strongly elevated by treatment of wild-type mice with WY-14,643, and this effect was also mediated via the PPARα as the upregulation of mRNA expression was not evident in the PPARα-null mice after one week of treatment.
Several groups have shown that sterol 12α-hydroxylase mRNA is increased following starvation in rodents (15, 17, 19) . Studies have shown that the PPARα is involved in mediating the fasting-induced upregulation of a number of genes in lipid metabolism (9-11) and we therefore used the PPARα-null mouse model to examine the mRNA level of sterol 12α-hydroxylase following fasting for 24
hours. Sterol 12α-hydroxylase mRNA expression was increased in wild-type animals by fasting but this upregulation was not present in the PPARα-null animals, demonstrating that the induction by fasting is also dependent on the PPARα ( Fig 1B) . A similar pattern of mRNA expression was also seen for ACO, with mRNA induced approximately 3-fold by fasting for 24 hours. This induction was also dependent on the PPARα, as the mRNA level was not elevated in the PPARα-knockout mice by this treatment. In contrast to WY-14,643 treatment, starvation increased the expression of the cholesterol 7α-hydroxylase mRNA levels in mouse in a PPARα-dependent manner.
In summary, the Northern blot data demonstrate that similar to ACO, the sterol 12α-hydroxylase gene is upregulated in the liver following treatment with WY-14,643 or starvation, and that this regulation is dependent on the PPARα.
Identification of a peroxisome proliferator-response element in the sterol 12 -
hydroxylase promoter region -The PPAR/RXR heterodimer recognizes a response element with a 13 bp core sequence consisting of AGGTCA A/T AGGTCA (a direct repeat 1 -DR1). Sequence analysis of the promoter regions of the mouse (19) and rat sterol 12α-hydroxylase genes (18) identified a conserved but imperfect DR1 sequence in the promoters, located at -120 and -106 bp respectively upstream of the ATG start site ( Fig. 2A) . It also appears that additional nucleotides in the flanking region of the PPRE element are important for PPARα/RXR heterodimer binding. Four to seven nucleotides 5' (20,21) of the PPRE core sequence are important for the function of the PPARα/RXR heterodimer and analysis of the rat 12α-hydroxylase PPRE flanking sequences identified 5 out of 7 conserved bases in the 5' extended half-site ( Fig. 2B ).
To determine whether the PPARα/RXR heterodimer can bind to the DR1 element identified in the rat promoter sequence, electrophoretic mobility shift assay was performed using in vitro translated PPARα and RXRα, together with 32 P-labeled oligonucleotides representing the PPRE of the ACO gene, the putative PPRE for sterol 12α-hydroxylase and mutated sterol 12α-hydroxylase PPREs, as shown in Fig. 2C . Neither PPARα nor RXR alone bound to the labeled probes ( Fig. 3 ). In the presence of both PPARα and RXR, there was a strong binding to the PPRE of ACO, which was further retarded using the RXR antibody. Binding, although weak, was detectable also for the sterol 12α-hydroxylase PPRE, which was also retarded using the RXR antibody. In order to further characterize the The PPAR influences bile acid composition following treatment with WY-14,643 -The sterol 12α-hydroxylase activity influences the ratio of cholic acid to chenodeoxycholic acid, and increased sterol 12α-hydroxylase activity is expected to result in increased cholic acid formation. We therefore determined whether the observed increase in sterol 12α-hydroxylase expression would affect bile acid composition. Unfortunately it was not possible to measure bile acids quantitatively since total bile was extracted from the gallbladders, which showed highly individual bile content. Therefore, the composition of bile acids were determined in bile using gas chromatography (Fig. 5A ). In control animals, the predominant bile acids were cholic acid and β-muricholic acid, but also present in smaller amounts were chenodeoxycholic, deoxycholic, ursodeoxycholic and ω- (13) . Our data shows that WY-14,643 treatment did not alter the expression of cholesterol 7α-hydroxylase in mouse, and it is therefore reasonable to assume that the treatment does not change total bile acid production to any larger extent, indicating that PPARα mediates a quantitative regulation of cholic acid synthesis in the mouse.
In addition to the now established involvement of the PPARα in regulating gene expression in response to peroxisome proliferators, such as the fibrates, this receptor was recently shown also to mediate the effects of fasting and diabetes on the expression of many enzymes involved in lipid metabolism (8) (9) (10) (11) . The Recently del-Castillo-Olivares et al (22) showed that the α 1 -fetoprotein transcription factor is required for the expression of sterol 12α-hydroxylase. The α 1 -fetoprotein binding site identified by this group is in fact the same site as the PPRE now identified by us. Notably, the mutations which we introduced into the PPRE resulted in a substantially lower promoter activity than the wild-type promoter (approximately 95% lower), which could be explained by a distrubance in the binding site for α 1 -fetoprotein transcription factor. During our transfection experiments, a decreased promoter activity was obtained with co-transfection of PPARα and the sterol 12α-hydroxylase promoter, and this could also be explained by competition between PPARα and the α 1 -fetoprotein transcription factor for the same binding site. On the other hand, administration of fibrates to humans causes a decreased activity of the cholesterol 7α-hydroxylase which may result in decreased bile acid formation and increased cholesterol saturation and a subsequent increased risk of gallstone formation (12, 26, 27) .
The important roles of the nuclear receptors farnesoid X receptor (FXR) and
the liver X receptor alpha (LXRα) in regulation of bile acid metabolism have recently been demonstrated (28, 29) . The transcription of the genes encoding cholesterol 7α-hydroxylase and ileal bile acid binding protein appears to be regulated by the interaction of these receptors with specific response elements in the 5'-flanking regions of the genes (30, 31) . Our data demonstrate the involvement of another nuclear receptor, the PPARα, in the regulation of bile acid metabolism. It appears that the PPARα plays a dual role in regulation of fatty acid metabolism as well as in regulation of cholesterol metabolism by modulating expression of enzymes involved in the biosynthesis of bile acids. 
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